Author:
Merchant Alisha,Tania Vidal H.,Baptiste Mahaly,Ehsan Hashimul,Kaneko Gen
Reference96 articles.
1. Agency U.S.E.P. (2021). Toxicity forecasting: Advancing the next generation of chemical evaluation.
2. Preliminary identification of potential vaccine targets for the COVID-19 Coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies;Ahmed;Viruses,2020
3. The proximal origin of SARS-CoV-2;Andersen;Nature Medicine,2020
4. AstraZeneca. (2021a). AZD1222 US Phase III primary analysis confirms safety and efficacy. .
5. AstraZeneca. (2021b). Phase III double-blind, placebo-controlled study of AZD1222 for the prevention of COVID-19 in adults. .